The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabozantinib (C) ± atezolizumab (A) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Expansion cohorts from the open-label phase 1b COSMIC-021 study.
 
Neeraj Agarwal
Research Funding - Amgen (Inst); Arvinas (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); crispr therapeutics (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); Gilead Sciences (Inst); Immunomedics (Inst); Janssen (Inst); Lilly (Inst); Merck (Inst); Nektar (Inst); ORIC Pharmaceuticals (Inst); ORIC Pharmaceuticals (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Exelixis; Pfizer
 
Ulka Vaishampayan
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Exelixis; Gilead Sciences; Janssen Oncology; Merck Serono; Mural; Pfizer; Pfizer/Astellas; Sumitomo Pharma Oncology
Research Funding - Bristol-Myers Squibb; Merck KGaA
 
Jingsong Zhang
Honoraria - AstraZeneca/MedImmune; Dendreon; Sanofi
Consulting or Advisory Role - AstraZeneca/MedImmune; Dendreon; Sanofi
 
Xavier Artignan
No Relationships to Disclose
 
Begoña Mellado
Speakers' Bureau - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen; Novartis; Pfizer; Roche; Sanofi
Research Funding - Bayer; Janssen; Roche
 
Shirley Wong
Honoraria - Bayer; BMSi
Consulting or Advisory Role - Merk Sharpe & Dome; Pfizer
Research Funding - Astellas Pharma (Inst); Eisai (Inst); Roche (Inst)
Expert Testimony - Slater and Gordon Law Company
Travel, Accommodations, Expenses - Bayer
 
Omi Parikh
Honoraria - Bayer; Janssen; Janssen
Consulting or Advisory Role - Janssen
 
Daniel Castellano
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Lilly; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Sanofi
Research Funding - Janssen Oncology (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Bristol-Myers Squibb; Novartis; Pfizer; Roche
 
Joaquina Baranda
Stock and Other Ownership Interests - Aprea Therapeutics; Merus NV; Moderna Therapeutics; Zymeworks
Research Funding - Astellas Pharma (Inst); Chungchun Intellicrown (Inst); Exelixis (Inst); IMPAC Medical Systems (Inst); Merck (Inst); Poseida (Inst); Sanofi (Inst); Synermore (Inst); Xencor (Inst)
 
Denise Williamson
Employment - Exelixis; IQvia
Stock and Other Ownership Interests - Exelixis; Exelixis (I)
 
Lavanya Gunachandran
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Xiang Guo
Employment - Exelixis
Stock and Other Ownership Interests - Exelixis
 
Prachi Nandoskar
Employment - Exelixis; Pfizer
Stock and Other Ownership Interests - Exelixis; Pfizer
Travel, Accommodations, Expenses - Exelixis; Pfizer
 
Bradley McGregor
Consulting or Advisory Role - Arcus Biosciences; Astellas Pharma; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Eisai; Exelixis; Genmab; Gilead Sciences; Loxo/Lilly; Pfizer; Seattle Genetics/Astellas
Research Funding - Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Exelixis (Inst); Pfizer/EMD Serono (Inst); Seattle Genetics/Astellas (Inst)
 
Sumanta Pal
Speakers' Bureau - IntrinsiQ; MJH Life Sciences; Peerview
Travel, Accommodations, Expenses - crispr therapeutics; Exelixis; Ipsen